![](https://d3ilqtpdwi981i.cloudfront.net/rkYVkbIPWvwvbMfFTp_6RErK0MQ=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/e7/c4/f7/e7c4f72d-2d30-4a1b-aef9-63c8802fa6b2/thumbnail_00ceb3b4-7225-42ef-b449-13412d80f09e.jpg)
Article
Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis
Cancers
(2021)
Disciplines
Publication Date
2021
Citation Information
Peeyush Lala, Guillermo Antonio De Paz Linares and Mousumi Majumder. "Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis" Cancers (2021) Available at: http://works.bepress.com/peeyush-lala/4/